 Provided by ReachMD
Making Clinical Trials More Relevant
on Inspired to Act
Presented by Pri-Med
How can clinical trials be made above reproach? How can a healthcare professional best interpret the results of clinical trials? Dr. Steven Nissen, chairman of the department of cardiovascular medicine at the Cleveland Clinic and past-president of the American College of Cardiology, joins Host Dr. Martin A. Samuels to discuss these and other topics.
 Dr. Martin A. Samuels is the founding chair, Department of Neurology, Brigham and Women's Hospital, and professor of neurology at Harvard Medical School. Dr. Samuels completed his internship, residency and chief residency in internal medicine at Boston City Hospital and neurology residency at Massachusetts General Hospital. He was chief of the neurology service at Brockton-West Roxbury VA Medical Center in Brockton, Massachusetts, for 11 years before assuming the position in 1988 of chief of neurology at the Brigham and Women's Hospital and director of the Harvard Longwood Neurology Program.Dr. Samuels is senior medical advisor at Pri-Med. He is also a fellow of the American Academy of Neurology, a master of the American College of Physicians. Dr. Samuels has won numerous honors, including the first Harvard Medical School Faculty Prize for Excellence in Teaching and, from the American Academy of Neurology, both the 2006 A.B. Baker Award for Lifetime Achievement in Neurological Education and the 2007 H. Houston Merritt Award for Clinically Relevant Research.
 Dr. Steven Nissen is chairman of the department of cardiovascular medicine at the Cleveland Clinic, as well as past president of the American College of Cardiology. Dr. Nissen's research during the last two decases has focused on application of intravascular ultrasound imaging to the assessment of progression and regression of coronary atherosclerosis. His contributions to scientific literature include approximately 300 journal articles in the New England Journal of Medicine and and the Journal of the American Medical Association and others, and over 50 book chapters. In recent years, Dr. Nissen has written extensively on the subject of drug safety.
ReachMD, an innovative communications company, provides thought-provoking medical news and information to healthcare practitioners. Established to help increasingly time-constrained medical providers stay abreast of new research, treatment protocols and continuing education requirements, ReachMD delivers innovative and informative radio programming via XM Satellite Radio Channel 160 and online streaming developed by healthcare professionals for healthcare professionals.
The viewpoint expressed in this article is the opinion of the author and is not necessarily the viewpoint of the owners or employees at Healthcare Staffing Innovations, LLC.
RECOMMEND THIS ARTICLE
You must be logged in
to recommend articles
|
